• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中文人群中受教育程度低的慢性阻塞性肺疾病患者的临床特征及全因死亡率风险。

Clinical characteristics and risk of all-cause mortality in low education patients with chronic obstructive pulmonary disease in the Chinese population.

机构信息

Department of Respiratory and Critical Care Medicine, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, China.

出版信息

J Glob Health. 2023 Dec 1;13:04163. doi: 10.7189/jogh.13.04163.

DOI:10.7189/jogh.13.04163
PMID:38033249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10693353/
Abstract

BACKGROUND

Education levels play a critical role in the development of chronic obstructive pulmonary disease (COPD), which mainly affects the elderly, who generally have a low level of education in China. We aimed to investigate the association between education level and COPD clinical characteristics and outcomes, especially the effects of education level on the all-cause mortality of COPD in the Chinese population.

METHODS

We retrieved data collected between December 2016 and June 2020 in the RealDTC, an ongoing multicenter, real-world study on the status of diagnosis and treatment of COPD. The patients were classified into low- and high-education groups. We extracted data on demographics, pulmonary function, Global Initiative for Chronic Obstructive Lung Disease (GOLD) grades, modified Medical Research Council (mMRC) scores, COPD Assessment Test (CAT) scores, exacerbation history, therapy, and comorbidities, and on mortality during three years of follow-up.

RESULTS

We included 4098 patients with COPD, of whom 3258 (79.5%) were of low education. This group had higher ages, CAT scores, mMRC scores, and numbers of exacerbations, as well as a greater proportion of females, never smokers, biofuel exposure, and GOLD grade 3. Logistic regression showed that being aged ≥65 years, being female, having biofuel exposure, having CAT scores of 20-29, and having ≥2 exacerbations were independently associated with having low education (P < 0.05). Furthermore, low-education COPD patients had a higher cumulative mortality risk during three years of follow-up than their high-education counterparts (hazard ratio (HR) = 1.75; 95% confidence interval (CI) = 1.17-2.61, P = 0.006).

CONCLUSIONS

Low-education COPD patients, who accounted for most of our sample, had a higher symptom burden, risk of exacerbation, and risk of all-cause mortality. Clinicians attending COPD patients should be more attentive of individuals with low education levels.

摘要

背景

教育水平在慢性阻塞性肺疾病(COPD)的发展中起着至关重要的作用,COPD 主要影响老年人,而中国老年人的受教育水平普遍较低。我们旨在探讨教育水平与 COPD 临床特征和结局之间的关系,特别是教育水平对中国人群 COPD 全因死亡率的影响。

方法

我们检索了 2016 年 12 月至 2020 年 6 月期间正在进行的、多中心、真实世界的 COPD 诊断和治疗现状研究(RealDTC)中收集的数据。患者被分为低教育组和高教育组。我们提取了人口统计学、肺功能、全球倡议慢性阻塞性肺疾病(GOLD)分级、改良的医学研究理事会(mMRC)评分、COPD 评估测试(CAT)评分、加重史、治疗和合并症以及 3 年随访期间的死亡率等数据。

结果

我们纳入了 4098 例 COPD 患者,其中 3258 例(79.5%)为低教育程度。这组患者年龄较大,CAT 评分、mMRC 评分和加重次数较高,女性、从不吸烟者、生物燃料暴露以及 GOLD 分级 3 的比例也较高。Logistic 回归显示,年龄≥65 岁、女性、生物燃料暴露、CAT 评分为 20-29 分和≥2 次加重与低教育程度独立相关(P<0.05)。此外,在 3 年随访期间,低教育程度 COPD 患者的累积死亡率风险高于高教育程度患者(危险比(HR)=1.75;95%置信区间(CI)=1.17-2.61,P=0.006)。

结论

在我们的样本中,大多数低教育程度 COPD 患者的症状负担、加重风险和全因死亡率较高。治疗 COPD 患者的临床医生应更加关注受教育程度较低的个体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3075/10693353/98376a138dbe/jogh-13-04163-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3075/10693353/c6dd3fe6a133/jogh-13-04163-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3075/10693353/98376a138dbe/jogh-13-04163-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3075/10693353/c6dd3fe6a133/jogh-13-04163-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3075/10693353/98376a138dbe/jogh-13-04163-F2.jpg

相似文献

1
Clinical characteristics and risk of all-cause mortality in low education patients with chronic obstructive pulmonary disease in the Chinese population.中文人群中受教育程度低的慢性阻塞性肺疾病患者的临床特征及全因死亡率风险。
J Glob Health. 2023 Dec 1;13:04163. doi: 10.7189/jogh.13.04163.
2
Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.慢性阻塞性肺疾病患者临床慢性阻塞性肺疾病问卷的决定因素:一项横断面观察性研究。
Respiration. 2020;99(7):606-616. doi: 10.1159/000507097. Epub 2020 Jul 13.
3
COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.在Humana医疗保险成员中,慢性阻塞性肺疾病(COPD)急性加重与改良的医学研究委员会量表及COPD评估测试的相关性。
Int J Chron Obstruct Pulmon Dis. 2016 Jan 14;11:111-21. doi: 10.2147/COPD.S94323. eCollection 2016.
4
Chronic obstructive pulmonary disease (COPD) assessment test scores corresponding to modified Medical Research Council grades among COPD patients.慢性阻塞性肺疾病(COPD)患者中与改良医学研究委员会分级相对应的COPD评估测试分数。
Korean J Intern Med. 2015 Sep;30(5):629-37. doi: 10.3904/kjim.2015.30.5.629. Epub 2015 Aug 27.
5
Does the 2017 global initiative for chronic obstructive lung disease revision really improve the assessment of Chinese chronic obstructive pulmonary disease patients? A multicenter prospective study for more than 5 years.2017 年全球慢性阻塞性肺疾病倡议修订版真的能改善中国慢性阻塞性肺疾病患者的评估吗?一项为期 5 年以上的多中心前瞻性研究。
Chin Med J (Engl). 2023 Nov 5;136(21):2587-2595. doi: 10.1097/CM9.0000000000002487.
6
The Clinical Characteristics and Outcomes in Non-Frequent Exacerbation Patients with Chronic Obstructive Pulmonary Disease in the Chinese Population.中国人群中慢性阻塞性肺疾病非频繁加重患者的临床特征和结局。
Int J Chron Obstruct Pulmon Dis. 2023 Aug 15;18:1741-1751. doi: 10.2147/COPD.S417566. eCollection 2023.
7
GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.慢性阻塞性肺疾病的GOLD分类:症状与急性加重风险评估标准中的不一致性
COPD. 2017 Feb;14(1):1-6. doi: 10.1080/15412555.2016.1230844. Epub 2016 Oct 10.
8
Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity.将新的慢性阻塞性肺疾病(COPD)全球倡议(GOLD)分期系统应用于美国基层医疗队列,并与医生和患者对严重程度的印象进行比较。
Int J Chron Obstruct Pulmon Dis. 2015 Jul 30;10:1477-86. doi: 10.2147/COPD.S78827. eCollection 2015.
9
Characteristics and risk factors for inconsistency between the risk of exacerbations and the severity of airflow limitation in COPD based on GOLD 2017: A retrospective, cross-sectional study.基于 GOLD 2017 的 COPD 加重风险与气流受限严重程度不一致的特征和危险因素:一项回顾性、横断面研究。
PLoS One. 2018 Mar 12;13(3):e0193880. doi: 10.1371/journal.pone.0193880. eCollection 2018.
10
Analysis of clinical characteristics, prognosis and influencing factors in patients with bronchiectasis-chronic obstructive pulmonary disease overlap syndrome: A prospective study for more than five years.支气管扩张-慢性阻塞性肺疾病重叠综合征患者的临床特征、预后及影响因素分析:一项为期五年以上的前瞻性研究。
J Glob Health. 2024 Jun 28;14:04129. doi: 10.7189/jogh.14.04129.

引用本文的文献

1
Comparison of clinical outcome of COPD with asthma-like feature with different inhalation therapies: a real-world study in the prospective RealDTC cohort.不同吸入疗法治疗具有哮喘样特征的慢性阻塞性肺疾病的临床结局比较:前瞻性RealDTC队列的一项真实世界研究
BMC Pulm Med. 2025 Jul 2;25(1):294. doi: 10.1186/s12890-025-03767-x.
2
Social determinants of health on all-cause and cause-specific mortality in US adults with chronic obstructive pulmonary disease: NHANES 2005-2018.美国慢性阻塞性肺疾病成年人全因死亡率和特定病因死亡率的健康社会决定因素:2005 - 2018年美国国家健康与营养检查调查
PLoS One. 2025 May 15;20(5):e0322654. doi: 10.1371/journal.pone.0322654. eCollection 2025.
3

本文引用的文献

1
Chronic obstructive pulmonary disease (COPD) mortality trends worldwide: An update to 2019.慢性阻塞性肺疾病(COPD)全球死亡率趋势:2019 年更新。
Respirology. 2022 Nov;27(11):941-950. doi: 10.1111/resp.14328. Epub 2022 Jul 13.
2
Chronic obstructive pulmonary disease and the mortality risk in male older adults: Role of socioeconomic factors.慢性阻塞性肺疾病与老年男性的死亡风险:社会经济因素的作用。
Arch Gerontol Geriatr. 2022 Sep-Oct;102:104741. doi: 10.1016/j.archger.2022.104741. Epub 2022 Jun 1.
3
Association between socioeconomic status and chronic obstructive pulmonary disease in Jiangsu province, China: a population-based study.
Clinical characteristics and outcomes of chronic obstructive pulmonary disease patients with family history of chronic airway disease.
有慢性气道疾病家族史的慢性阻塞性肺疾病患者的临床特征及预后
Ann Med. 2025 Dec;57(1):2477299. doi: 10.1080/07853890.2025.2477299. Epub 2025 Mar 12.
4
Impact of intensive health education on influenza vaccination and acute exacerbations in outpatients with chronic obstructive pulmonary disease: a real-world study.强化健康教育对慢性阻塞性肺疾病门诊患者流感疫苗接种及急性加重的影响:一项真实世界研究
J Glob Health. 2025 Mar 7;15:04047. doi: 10.7189/jogh.15.04047.
5
The treatment responses among different inhalation therapies for GOLD group E patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病GOLD E组患者不同吸入疗法的治疗反应。
J Glob Health. 2025 Feb 21;15:04055. doi: 10.7189/jogh.15.04055.
6
The associations between modifiable risk factors and constipation: a comprehensive mendelian randomization study.可改变的风险因素与便秘的相关性:一项综合的孟德尔随机化研究。
BMC Gastroenterol. 2024 Oct 17;24(1):370. doi: 10.1186/s12876-024-03384-8.
7
Impact of exacerbation history on future risk and treatment outcomes in chronic obstructive pulmonary disease patients: A prospective cohort study based on Global Initiative for Chronic Obstructive Lung Disease (GOLD) A and B classifications.基于慢性阻塞性肺疾病全球倡议(GOLD)A 和 B 分类的前瞻性队列研究:加重史对慢性阻塞性肺疾病患者未来风险和治疗结局的影响。
J Glob Health. 2024 Oct 11;14:04202. doi: 10.7189/jogh.14.04202.
8
Predictive Value of CCQ and its Subdomains for Hospitalized Exacerbations in Chronic Obstructive Pulmonary Disease: A 3-Year Observational Prospective Study.慢性阻塞性肺疾病患者住院急性加重期CCQ及其子领域的预测价值:一项为期3年的观察性前瞻性研究。
J Gen Intern Med. 2025 May;40(7):1550-1558. doi: 10.1007/s11606-024-09067-0. Epub 2024 Oct 1.
9
Impact of Income-to-Poverty Ratio on Long-Term Mortality of Persons with Chronic Liver Disease in the USA, 1999-2018.1999-2018 年美国收入贫困比对慢性肝病患者长期死亡率的影响。
Dig Dis. 2024;42(5):473-485. doi: 10.1159/000539858. Epub 2024 Jun 17.
10
Development and validation of a nomogram model for mortality prediction in stable chronic obstructive pulmonary disease patients: A prospective observational study in the RealDTC cohort.稳定期慢性阻塞性肺疾病患者死亡率预测列线图模型的建立与验证:真实世界 COPD 诊疗数据队列研究。
J Glob Health. 2024 Feb 23;14:04049. doi: 10.7189/jogh.14.04049.
中国江苏省社会经济地位与慢性阻塞性肺疾病的关系:一项基于人群的研究。
Chin Med J (Engl). 2021 Jun 22;134(13):1552-1560. doi: 10.1097/CM9.0000000000001609.
4
Longitudinal Evaluation of the Relationship Between Low Socioeconomic Status and Incidence of Chronic Obstructive Pulmonary Disease: Korean Genome and Epidemiology Study (KoGES).韩国基因与流行病学研究(KoGES):社会经济地位低与慢性阻塞性肺疾病发病相关性的纵向评估。
Int J Chron Obstruct Pulmon Dis. 2021 Jan 5;15:3447-3454. doi: 10.2147/COPD.S276639. eCollection 2020.
5
Current Status of the Treatment of COPD in China: A Multicenter Prospective Observational Study.中国慢性阻塞性肺疾病的治疗现状:一项多中心前瞻性观察研究
Int J Chron Obstruct Pulmon Dis. 2020 Dec 7;15:3227-3237. doi: 10.2147/COPD.S274024. eCollection 2020.
6
Characteristics of Patients with Chronic Obstructive Pulmonary Disease Exposed to Different Environmental Risk Factors: A Large Cross-Sectional Study.暴露于不同环境危险因素的慢性阻塞性肺疾病患者的特征:一项大型横断面研究。
Int J Chron Obstruct Pulmon Dis. 2020 Nov 6;15:2857-2867. doi: 10.2147/COPD.S267114. eCollection 2020.
7
Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort.教育对终身不吸烟者和长期戒烟者 COPD 严重程度和全因死亡率的影响:COSYCONET 队列研究结果。
Int J Chron Obstruct Pulmon Dis. 2020 Nov 5;15:2787-2798. doi: 10.2147/COPD.S273839. eCollection 2020.
8
Assessment of Value of Neighborhood Socioeconomic Status in Models That Use Electronic Health Record Data to Predict Health Care Use Rates and Mortality.利用电子健康记录数据预测医疗利用率和死亡率模型中邻里社会经济地位的评估价值。
JAMA Netw Open. 2020 Oct 1;3(10):e2017109. doi: 10.1001/jamanetworkopen.2020.17109.
9
Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations.慢性阻塞性肺疾病加重的定义、病因、发病机制及后果。
Clin Chest Med. 2020 Sep;41(3):421-438. doi: 10.1016/j.ccm.2020.06.007.
10
Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.1990-2017 年慢性呼吸道疾病的流行情况和可归因健康负担:2017 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2020 Jun;8(6):585-596. doi: 10.1016/S2213-2600(20)30105-3.